|
HS Code |
702491 |
| Generic Name | Oxacillin Sodium |
| Drug Class | Penicillinase-resistant penicillin antibiotic |
| Molecular Formula | C19H18N3NaO5S |
| Molecular Weight | 421.42 g/mol |
| Route Of Administration | Intravenous or intramuscular |
| Indications | Treatment of infections caused by penicillinase-producing staphylococci |
| Mechanism Of Action | Inhibits bacterial cell wall synthesis |
| Contraindications | Hypersensitivity to penicillins |
| Pregnancy Category | Category B |
| Storage Temperature | 20°C to 25°C (68°F to 77°F) |
| Appearance | White to off-white crystalline powder |
| Brand Names | Bactocill |
| Half Life | Approximately 0.5 to 1.5 hours |
| Excretion | Primarily renal |
As an accredited Oxacillin Sodium factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Oxacillin Sodium is packaged in a sterile, amber glass vial containing 1 gram of powder for injection, sealed with a rubber stopper. |
| Shipping | Oxacillin Sodium is shipped in tightly sealed, light-resistant containers to protect from moisture and contamination. It is transported under controlled room temperature, typically between 15–30°C. Packaging complies with regulations for pharmaceuticals, ensuring proper labeling and handling to maintain stability and safety during transit. Avoid exposure to excessive heat or freezing. |
| Storage | Oxacillin Sodium should be stored at controlled room temperature, typically between 20°C to 25°C (68°F to 77°F), and protected from light and moisture. Keep the container tightly closed and store in a dry place. Avoid exposure to excessive heat or freezing. Keep out of reach of children and discard any unused reconstituted solution after the specified period. |
|
Purity 99%: Oxacillin Sodium with purity 99% is used in pharmaceutical manufacturing, where it ensures consistent antibiotic potency in finished formulations. Sterile grade: Oxacillin Sodium of sterile grade is used in intravenous infusion therapies, where it minimizes the risk of contamination during administration. Micronized particle size: Oxacillin Sodium with micronized particle size is used in oral suspension preparations, where it promotes rapid dissolution and absorption. Sodium content 4.3-4.9%: Oxacillin Sodium with sodium content 4.3-4.9% is used in injectable solutions, where it maintains electrolyte balance for patient safety. Stability temperature ≤25°C: Oxacillin Sodium with stability temperature ≤25°C is used in hospital pharmacy storage, where it ensures long-term chemical stability and efficacy. Water content ≤1%: Oxacillin Sodium with water content ≤1% is used in lyophilized powder formulations, where it extends shelf life and prevents degradation. Endotoxin level <5 EU/mg: Oxacillin Sodium with endotoxin level <5 EU/mg is used in parenteral drug production, where it reduces the risk of adverse immune reactions in patients. Molecular weight 421.43 g/mol: Oxacillin Sodium with molecular weight 421.43 g/mol is used in dosage calculations, where it guarantees precise therapeutic dosing. Low impurity ≤0.1%: Oxacillin Sodium with low impurity ≤0.1% is used in clinical antibiotic therapies, where it ensures safety and minimizes side effects. High solubility: Oxacillin Sodium with high solubility is used in reconstitution of injection vials, where it enables efficient drug preparation for immediate use. |
Competitive Oxacillin Sodium prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Antibiotic resistance keeps making headlines, and for good reason. Healthcare professionals find themselves facing more patients with infections that don’t budge with basic penicillin. Oxacillin Sodium, which belongs to the penicillin group but sports a resilient structure, offers a proven answer when doctors run into nasty staph infections that ordinary drugs won’t handle. Decades of clinical use give this drug a place at the bedside and in serious infection management, especially for cases involving staphylococci that pump out penicillinase, an enzyme breaking down regular penicillin.
The sterile, injectable form of Oxacillin Sodium often comes as a powder, which clinics or pharmacies then mix with sterile water before use. Most vials contain 1 to 2 grams per bottle, although other sizes exist for hospitals that plan for large-scale use. Hospitals do not select this drug based on tradition—they look at surveillance data, track patterns of resistance, and trust Oxacillin Sodium because it holds its ground against pathogens that shrug off first-line treatments.
People sometimes think of penicillins as “old drugs,” but experience shows that Oxacillin Sodium keeps its value because it targets the bacteria most likely to cause trouble in surgical wards, intensive care units, and for immunocompromised patients. I’ve seen its impact on neonatal wards, for example, where controlling staph outbreaks can prevent severe illness in already fragile babies. Swift identification of methicillin-sensitive Staphylococcus aureus (MSSA) locks in Oxacillin Sodium as a reliable next step. Delay in using the right antibiotic drives up death rates and hospital stays, so Oxacillin Sodium serves a direct, life-saving role.
In practice, doctors administer Oxacillin Sodium by slow intravenous injection or infusion. This form of delivery means the drug gets right into the patient’s bloodstream, bypassing the stomach where digestive juices might destroy a weaker antibiotic. Care teams monitor patients for allergic reactions and kidney function, just as they do for other penicillins. Pharmacists reconstitute each dose under strict conditions to maintain sterility. Because this drug specifically blocks the enzymes that make certain bacteria resistant, its use is backed by a clear mechanism. Bacteria evolve, but Oxacillin Sodium keeps up, provided medical teams support it with proper stewardship—avoiding overuse and limiting the emergence of resistance.
Not all penicillins carry the same punch. Standard penicillin G gets knocked out by penicillinase-producing staph. Oxacillin Sodium, with its extra chemical tweaks, avoids being chopped up by that enzyme. This sets it in the same class as methicillin, but, thanks to stability and safety, clinicians often favor Oxacillin Sodium for most treatment courses. Methicillin itself is rarely used these days, partly because of potential side effects on the kidneys. Nafcillin or flucloxacillin play similar roles in other countries, but Oxacillin Sodium dominates where supply chains or medical routines call for its steadfast profile.
Comparing Oxacillin Sodium to broader-spectrum drugs, such as cefazolin or vancomycin, highlights another strength. While vancomycin covers more resistant bacteria like MRSA, clinicians hold it back for severe cases because of side effect concerns and the risk of developing further resistance. Overuse of broad-spectrum agents compresses future treatment options and damages patient microbiomes. Where MSSA is proven, Oxacillin Sodium remains the targeted, effective answer—it works fast and clears bacteria with less risk of collateral damage compared to heavier drugs.
Oxacillin Sodium doesn’t work for everyone, especially those with a history of severe allergy to beta-lactam antibiotics. Medical teams check records closely, and sometimes run test doses under supervision. For patients at risk, alternatives like clindamycin, daptomycin, or linezolid exist, but these usually reserve for special cases because they’re either pricier, carry tougher monitoring, or introduce more side effects. Doctors weigh these options—balancing best outcomes, fastest cure times, and overall safety.
Using Oxacillin Sodium with intention supports successful infection control in hospitals. Antibiotic stewardship teams set up guidelines and track usage to make sure the drug holds onto its power. This means not using it just in case, but waiting for lab confirmation and sticking closely to the right dose and length of therapy. Hospitals connected to microbiology labs turn around staph identification quickly, but community facilities sometimes wait extra hours or even days for culture results. Quick action with the right medicine shortens illness, reduces hospital costs, and stops bacteria from spreading beyond the patient’s room.
Each vial of Oxacillin Sodium comes carefully sealed to guarantee potency. Powder-for-injection preparations typically offer either 1g or 2g strength. Pharmacists report that vials keep their integrity through common transport and storage settings: dry, moderate room temperature in the pharmacy, refrigeration after reconstitution when required. A dry, white powder signals a fresh product. Pharmacy staff inspect for clumping or discoloration, catching anything amiss before prepping a patient’s dose. Such vigilance, more than any data sheet, protects real lives in real clinics.
Every label spells out exact sodium content, a critical specification for patients with heart or kidney problems. High sodium loads can push a patient into fluid overload, so the clinical team tracks this number and adjusts other medications, food, and fluids when necessary. These details keep Oxacillin Sodium a safe choice as long as the entire team is paying attention and communicating well. Training pharmacy and nursing staff about correct mixing and administration techniques pays off directly—no shortcuts, no guesswork, just consistent, reliable care for sick people.
Over time, researchers have studied staph susceptibility trends and report that Oxacillin Sodium still beats out other drugs for treating penicillinase-producing staphylococci. Bacterial resistance patterns get complicated—no one wants to see resistance to this workhorse, so laboratories run frequent sensitivity testing, especially in high-risk wards. Infectious disease specialists work alongside pharmacists, double-checking therapy choices and coaching less-experienced staff.
Recent hospital infection data shows that early, precise use of Oxacillin Sodium churns out better results in bloodstream infections. Patients see quicker fevers break and leave the hospital sooner. That’s a win for them and for the health system at large. This practical evidence connects research data to patient bedsides daily—no theoretical argument, just lives saved and recovery accelerated.
Not every country gets the same access to high-quality Oxacillin Sodium. Supply chain disruptions, regulatory barriers, and local manufacturing differences change what is on hand in hospitals. Some areas rely on imports, which come with delays or sudden shortages when transport channels jam up. I have watched clinicians in low- and middle-income regions scramble to substitute other antibiotics, raising both costs and risks. When Oxacillin Sodium flows reliably, wards keep dangerous infections under control. Local production standards need to stay tight so that quality never slips, even as companies compete and prices shift over time.
Doctors and pharmacists keep a backup plan, especially during outbreaks or natural disasters. Some hospitals stock larger reserves or spread orders across several suppliers. These are practical precautions, and they mean that people with serious infections do not face dangerous treatment delays.
Hospital care gets more complex each year, with more patients undergoing surgery, cancer treatment, transplants, and intensive care. These advances save lives but make hospital-acquired infections a constant threat. Oxacillin Sodium finds its greatest value as a precise, reliable tool in this high-risk context. Unfocused treatment with heavier, broad-spectrum antibiotics causes more harm than good, fueling C. difficile outbreaks or resistance in gut bugs.
In my own clinical experience, working closely with stewardship and infection control teams, targeted therapy ensures the patient receives the least disruptive, most curative drug possible. Oxacillin Sodium lets doctors spare those big guns for when they’re truly needed without cutting any corners on infection cure rates.
Hospitals must tackle several challenges to keep Oxacillin Sodium an effective cornerstone of therapy. Thus, quick and accurate lab testing rises to the top of the list. Investment in rapid diagnostics speeds up decision-making and shortens treatment delays.
Education matters, too. Doctors, nurses, and pharmacists benefit from updates on resistance patterns, allergy management, and optimal dosing. Hospitals that build regular teaching sessions and peer feedback into routines see better patient results and fewer errors in administration.
Finally, governments and health agencies can collaborate to strengthen supply chains and guarantee the availability of high-quality antibiotics. Regulatory checks on manufacturing plants—wherever they may be—back up doctors’ trust in the vials at the bedside. Policy solutions to promote local production, along with international cooperation, help cushion against sudden shortages that put patients at risk.
Ending staph infections early means less time in bed, fewer days of missed work or school, and far lower costs for families. Oxacillin Sodium stands out as a medicine that most clinicians use regularly. There's little glamour, but daily use offers life-changing results. Most patients know it simply as “the antibiotic that worked,” while behind the scenes, a network of pharmacy, nursing, laboratory science, and infectious disease care makes that outcome possible.
I recall working with a team on a pediatric ward where an outbreak threatened to sideline dozens of young patients. Strategic deployment of Oxacillin Sodium, coupled with prompt hygiene interventions, halted the infection’s spread. Parents left with healthy kids and deep gratitude for care that, outwardly, looked unremarkable but relied on smart, coordinated medicine.
Antibiotic resistance is not going away any time soon, and every program’s success depends on sticking to what works without overreaching. By holding Oxacillin Sodium for the infections it's meant to treat, supporting timely access, and training up every layer of the healthcare system, hospitals continue to keep severe staph infections on a short leash.
Early successes with antibiotics gave people faith in medical progress, and stories of rapid recovery shaped public trust. Keeping that trust alive in the face of tougher bugs and global challenges means not just developing new drugs, but protecting tried-and-true agents like Oxacillin Sodium.
While its profile might seem familiar to seasoned clinicians, its value stays fresh where there’s strong stewardship, effective supply chain management, and careful attention to the nuts and bolts of infection treatment.
Oxacillin Sodium represents more than just another antibiotic on the shelf. Every dose given, every infection controlled, reflects a continuing commitment to evidence-based, patient-centered care. Hospitals and clinics that protect the quality and availability of Oxacillin Sodium safeguard their ability to fight back against staph infections—today and into the future.
So, while the drug itself may lack the glitz of cutting-edge discovery, its story is still being written by health workers around the globe who turn sound science into better, safer lives every single day.